Articles written for the GLP list the source as Genes and Science. All other articles were written for the sources noted with excerpts provided by the GLP.

Why are Alzheimer’s and dementia rates falling in Europe and the U.S.?

New York Times&nbsp|&nbsp
The risk for a person to develop dementia over a lifetime is now 13 percent lower than it was in ...

Vaccines will be in short supply when developed. Here’s a way to prioritize who gets one

New York Times&nbsp|&nbsp
A preliminary plan devised by the Centers for Disease Control and Prevention this spring gives priority to health care workers, then ...

Coronavirus survivors’ plasma offers ‘modest’ recovery boost for infected patients, small study suggests

New York Times&nbsp|&nbsp
A small study of patients who were severely ill from the coronavirus hints that treatment with antibodies from recovered patients ...

Teenager’s experimental gene therapy treatment could change the lives of millions of sickle cell patients worldwide

New York Times&nbsp|&nbsp
Meet Helen Obando, a shy 16-year-old who likes to dance when her body isn’t ravaged by the debilitating symptoms of ...

Should we eat less red meat? There’s no solid evidence behind that advice, dietary expert panel says

New York Times&nbsp|&nbsp
Public health officials for years have urged Americans to limit consumption of red meat and processed meats because of concerns ...

Bringing us closer to ‘once-in-a-lifetime’ hemophilia treatment with experimental gene therapies

New York Times&nbsp|&nbsp
Scientists are edging closer to defeating a longtime enemy of human health: hemophilia, the inability to form blood clots. After ...

Genetic crystal ball? Forecasting 5 serious diseases with algorithm that checks 6.6 million DNA spots

New York Times&nbsp|&nbsp
Scientists have created a powerful new tool to calculate a person’s inherited risks for heart disease, breast cancer and three ...

Why you may need a second, or even third, opinion on your genetic test results

New York Times&nbsp|&nbsp
[Radiology resident Joshua Clayton] sent a sample of his saliva to 23andMe, the genetic testing company. His report was pretty ...

Immunotherapy as a last resort for terminal cancer patients

New York Times&nbsp|&nbsp
Dr. Oliver Sartor has a provocative question for patients who are running out of time. Most are dying of prostate ...

‘All of Us’: NIH biobank set to collect genomes of 1 million people to address chronic diseases

New York Times&nbsp|&nbsp
This spring, the National Institutes of Health will start recruiting participants for one of the most ambitious medical projects ever ...

Immunotherapy mystery: Drugs treat ovarian cancer ‘when they should not have’

Independent&nbsp|&nbsp
[Four women with rare ovarian cancer], strangers to one another living in different countries, asked their doctors to try new ...

Why news of cloned monkeys doesn’t mean humans are next

New York Times&nbsp|&nbsp
Researchers in China reported on [January 24] that they have created two cloned monkeys, the first time that primates have ...

Gene therapy challenge: Overcoming shortage of key and expensive viruses

New York Times&nbsp|&nbsp
Eager to speed development of revolutionary treatments, the Food and Drug Administration recently announced that it would expedite approval of ...
Glyberia

Why do gene therapy treatments cost so much?

New York Times&nbsp|&nbsp
The first gene therapy treatment in the United States was approved recently by the Food and Drug Administration, heralding a new ...

Unlocking the past: DNA ancestry tests rewrite family histories

New York Times&nbsp|&nbsp
A growing number of companies now offer DNA tests that promise to pinpoint a customer’s heritage and, with permission, to ...
s

Harvard’s George Church: CRISPR could give us pig-to-human organ transplants within 2 years

New York Times&nbsp|&nbsp
In a bold scientific step that helps open the door to organ transplants from animals, researchers at Harvard and a ...

FDA approves 23andMe direct-to-consumer genetic tests for 10 diseases including Alzheimer’s, Parkinson’s

New York Times&nbsp|&nbsp
For the first time, the Food and Drug Administration said it would allow a company to sell genetic tests for ...

Is DNA destiny when it comes to heart disease?

New York Times&nbsp|&nbsp
A new analysis of data from more than 55,000 people provides an answer. It finds that by living right — ...

Rethinking obesity: More about genes than willpower

New York Times&nbsp|&nbsp
[A] nationally representative survey of 1,509 adults...by NORC at the University of Chicago, an independent research institution...found that concerns about ...

Business booming for stem cell therapy clinics despite dearth of evidence of effectiveness

New York Times&nbsp|&nbsp
Out of nowhere, over the past two to three years, the clinics have sprung up — 570 in the United ...

Americans disinterested in using science to build better humans

New York Times&nbsp|&nbsp
Americans aren’t very enthusiastic about using science to enhance the human species. Instead, many find it rather creepy. A new ...

CRISPR co-discoverer Emmanuelle Charpentier furthering advances in gene editing

New York Times&nbsp|&nbsp
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Emmanuelle Charpentier — one ...

Genetic screening for breast cancer offers information, but often no guidance

New York Times&nbsp|&nbsp
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. At a time when ...

When Alzheimer’s is inevitable, is genetic screening any use?

New York Times&nbsp|&nbsp
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Marty and Matt Reiswig, ...

Middle-aged white Americans increasingly falling victim to suicide

New York Times&nbsp|&nbsp
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.  Something startling is happening ...

Verdict on ‘devious defecator’ case: Employees protected from genetic discrimination

New York Times&nbsp|&nbsp
The case that experts believe is the first to go to trial under the law involves something completely different: an ...

Will organic farmers embrace precision gene editing if ancient wild traits are restored?

New York Times&nbsp|&nbsp
What’s in a name? A lot, if the name is genetically modified organism, which many people are dead set against ...

New blood test could replace biopsy in detecting and monitoring cancer

New York Times&nbsp|&nbsp
In the usual cancer biopsy, a surgeon cuts out a piece of the patient’s tumor, but researchers in labs across ...